• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用血小板聚集定量生物测定法快速、选择性地测量血小板活化因子。

Rapid and selective measurement of platelet-activating factor using a quantitative bioassay of platelet aggregation.

作者信息

Ammit A J, O'Neill C

机构信息

Human Reproduction Unit, Royal North Shore Hospital of Sydney, New South Wales, Australia.

出版信息

J Pharmacol Methods. 1991 Aug;26(1):7-21. doi: 10.1016/0160-5402(91)90050-f.

DOI:10.1016/0160-5402(91)90050-f
PMID:1921410
Abstract

A bioassay for the measurement of platelet-activating factor (PAF) based on the quantification of platelet aggregation was developed. The method used a platelet analyzer in conjunction with a multiwelled micromixing device and whole blood collected from male New Zealand White rabbits. This bioassay can be nonselective and used to quantitate platelet aggregation induced by any activator. The EC50 for platelet-activating factor, arachidonic acid, and adenosine diphosphate were 0.0232, 55, and 10 microM, and at these concentrations the half maximal aggregation response occurred at 7.5, 10.0, and 12.5 min, respectively. The bioassay was capable of the sensitive quantification of platelet aggregation in small volumes (50 microL) of citrated rabbit whole blood, using a short (i.e., 15-min) incubation period. This enabled multiple bioassays to be performed without the need for a large volume of whole blood to be collected from the rabbit. Selective measurement of platelet-activating factor was achieved by adding inhibitors of arachidonic acid- and adenosine diphosphate-dependent pathways of platelet activation, that is, acetylsalicyclic acid and phosphoenolpyruvate/pyruvate kinase, respectively, to the citrated rabbit whole blood immediately before bioassay. These inhibited arachidonic acid- and adenosine diphosphate-induced platelet aggregation, but had no effect on platelet aggregation induced by platelet-activating factor. Platelet-activating factor was selectively inhibited by its receptor antagonist BN 52021. This method for measuring platelet-activating factor was reproducible; at the EC50, the inter- and intrabioassay coefficients of variation were within acceptable limits at 13.17% and 9.75%, respectively.

摘要

开发了一种基于血小板聚集定量的血小板活化因子(PAF)生物测定法。该方法使用血小板分析仪结合多孔微混合装置以及从雄性新西兰白兔采集的全血。这种生物测定法可以是非选择性的,用于定量任何激活剂诱导的血小板聚集。血小板活化因子、花生四烯酸和二磷酸腺苷的半数有效浓度(EC50)分别为0.0232、55和10微摩尔,在这些浓度下,最大聚集反应的一半分别在7.5、10.0和12.5分钟出现。该生物测定法能够在短(即15分钟)孵育期内,对小体积(50微升)枸橼酸化兔全血中的血小板聚集进行灵敏定量。这使得无需从兔子采集大量全血就能进行多次生物测定。通过在生物测定前立即向枸橼酸化兔全血中加入血小板活化的花生四烯酸依赖性途径和二磷酸腺苷依赖性途径的抑制剂,即分别加入乙酰水杨酸和磷酸烯醇丙酮酸/丙酮酸激酶,实现了对血小板活化因子的选择性测量。这些抑制剂抑制了花生四烯酸和二磷酸腺苷诱导的血小板聚集,但对血小板活化因子诱导的血小板聚集没有影响。血小板活化因子被其受体拮抗剂BN 52021选择性抑制。这种测量血小板活化因子的方法具有可重复性;在EC50时,生物测定间和生物测定内的变异系数分别在可接受范围内,为13.17%和9.75%。

相似文献

1
Rapid and selective measurement of platelet-activating factor using a quantitative bioassay of platelet aggregation.使用血小板聚集定量生物测定法快速、选择性地测量血小板活化因子。
J Pharmacol Methods. 1991 Aug;26(1):7-21. doi: 10.1016/0160-5402(91)90050-f.
2
Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.三黄素可增强血小板活化因子受体拮抗剂对活化中性粒细胞诱导的血小板聚集的抗血小板活性。
Eur J Pharmacol. 1999 Jan 8;364(2-3):239-46. doi: 10.1016/s0014-2999(98)00815-2.
3
Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.血小板活化因子(PAF)受体拮抗剂可抑制花生四烯酸诱导的兔全血血小板聚集。
Lipids. 1991 Dec;26(12):1189-92. doi: 10.1007/BF02536529.
4
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.BN 52021对血小板活化因子(PAF-乙醚)诱导的血小板活化的特异性抑制作用及其与PAF-乙醚抑制剂海风藤酮和CV 3988的比较
Eur J Pharmacol. 1986 Apr 16;123(2):197-205. doi: 10.1016/0014-2999(86)90660-6.
5
Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.血小板活化因子拮抗剂对花生四烯酸诱导的血小板聚集和血栓素A2形成的影响。
Prostaglandins Leukot Essent Fatty Acids. 1990 Nov;41(3):181-2. doi: 10.1016/0952-3278(90)90087-2.
6
Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica.绣线菊中二萜生物碱的抗血小板聚集活性
Eur J Pharmacol. 2002 Aug 2;449(1-2):23-8. doi: 10.1016/s0014-2999(02)01627-8.
7
Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.血小板活化因子作为体内血小板聚集介质的短期和长期作用。
Circulation. 1993 Sep;88(3):1205-14. doi: 10.1161/01.cir.88.3.1205.
8
Histamine potentiates human platelet aggregation induced by platelet-activating factor.组胺可增强血小板活化因子诱导的人血小板聚集。
Int Arch Allergy Immunol. 1992;97(1):89-92. doi: 10.1159/000236101.
9
Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.结构相关的血小板活化因子拮抗剂Ro 19-3704对肾上腺素诱导的人血小板聚集的选择性抑制作用。
Br J Pharmacol. 1989 Apr;96(4):759-66. doi: 10.1111/j.1476-5381.1989.tb11880.x.
10
Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.KO-286011在体外和体内对血小板的血小板活化因子(PAF)抑制作用
Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):713-8. doi: 10.1007/BF00175717.

引用本文的文献

1
Rapid Ca2+-mediated activation of Rap1 in human platelets.人血小板中 Rap1 的快速 Ca2+ 介导激活
EMBO J. 1997 Jan 15;16(2):252-9. doi: 10.1093/emboj/16.2.252.
2
Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.血小板活化因子(PAF)受体拮抗剂可抑制花生四烯酸诱导的兔全血血小板聚集。
Lipids. 1991 Dec;26(12):1189-92. doi: 10.1007/BF02536529.